The public issue of Advanced Enzymes was subscribed 115.8 times on the last day of the offering.
The public issue of Advanced Enzymes was subscribed 115.8 times on the last day of the offering. Till 5pm on Friday, bids were received for 37.45 crore shares, against 32,34 lakh shares on offer, priced in a band of Rs 880-896 per share.
Bangalore-based staffing firm Quess Corp’s IPO was recently oversubscribed 144 times. Qualified institutional buyers (QIBs) bid for 8.64 crore shares against 9.18 lakh shares reserved for them, over subscription of more than 94 times.
High net worth individuals (HNIs) bid for 27 crore shares against 6.86 lakh shares reserved for them, bidding for 393 times of their quota. The retail portion was oversubscribed 11 times, with investors bidding for 1.8 crore shares against 16.2 lakh shares on offer. Employees, who were offered a discount of Rs 86 per share, bid for 42,834 shares against 25,188 shares offered to them. On Tuesday, the company allotted 13.71 lakh shares aggregating to Rs 122.85 crore to its anchor investors including DB International,Kuwait Investment Authority Fund, DSP BlackRock, HDFC Trustee, ICICI Prudential, Reliance Capital, Birla Sunlife, and IDFC, among others. The enzyme manufacturer reported a net profit of Rs 78.43 crore on total revenue of Rs 294.6 crore in the previous financial year. Healthcare and nutrition and bio-processing business of the company constitute 87.62% and 12.38%, respectively, of its total revenue.